These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
685 related articles for article (PubMed ID: 10448801)
1. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801 [TBL] [Abstract][Full Text] [Related]
2. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study. Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133 [TBL] [Abstract][Full Text] [Related]
3. Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: A pilot study. Purandare N; Oude Voshaar RC; Davidson Y; Gibbons L; Hardicre J; Byrne J; McCollum C; Jackson A; Burns A; Mann DM J Am Geriatr Soc; 2006 Sep; 54(9):1395-400. PubMed ID: 16970648 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492 [TBL] [Abstract][Full Text] [Related]
5. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging. Jobst KA; Barnetson LP; Shepstone BJ Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442 [TBL] [Abstract][Full Text] [Related]
6. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients. Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643 [TBL] [Abstract][Full Text] [Related]
8. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; O'Brien JT Neurology; 1999 Apr; 52(6):1153-8. PubMed ID: 10214736 [TBL] [Abstract][Full Text] [Related]
9. Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly. Koivumäki M; Ekblad L; Lantero-Rodriguez J; Ashton NJ; Karikari TK; Helin S; Parkkola R; Lötjönen J; Zetterberg H; Blennow K; Rinne JO; Snellman A Alzheimers Res Ther; 2024 May; 16(1):112. PubMed ID: 38762725 [TBL] [Abstract][Full Text] [Related]
10. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease. Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366 [TBL] [Abstract][Full Text] [Related]
11. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset. Hirono N; Hashimoto M; Yasuda M; Ishii K; Sakamoto S; Kazui H; Mori E Neurology; 2002 Mar; 58(5):743-50. PubMed ID: 11889238 [TBL] [Abstract][Full Text] [Related]
12. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. Hirono N; Yasuda M; Tanimukai S; Kitagaki H; Mori E Stroke; 2000 Jun; 31(6):1263-8. PubMed ID: 10835442 [TBL] [Abstract][Full Text] [Related]
13. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele. Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943 [TBL] [Abstract][Full Text] [Related]
14. APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years. Taylor JL; Scanlon BK; Farrell M; Hernandez B; Adamson MM; Ashford JW; Noda A; Murphy GM; Weiner MW Neurobiol Aging; 2014 Nov; 35(11):2479-2485. PubMed ID: 24929969 [TBL] [Abstract][Full Text] [Related]
15. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease. Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562 [TBL] [Abstract][Full Text] [Related]
16. APOE and modulation of Alzheimer's and frontotemporal dementia. Boccardi M; Sabattoli F; Testa C; Beltramello A; Soininen H; Frisoni GB Neurosci Lett; 2004 Feb; 356(3):167-70. PubMed ID: 15036621 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. Skoog I; Hesse C; Fredman P; Andreasson LA; Palmertz B; Blennow K Arch Neurol; 1997 Mar; 54(3):267-72. PubMed ID: 9074395 [TBL] [Abstract][Full Text] [Related]
18. Do cardiovascular risk factors explain the link between white matter hyperintensities and brain volumes in old age? A population-based study. Wang R; Fratiglioni L; Laveskog A; Kalpouzos G; Ehrenkrona CH; Zhang Y; Bronge L; Wahlund LO; Bäckman L; Qiu C Eur J Neurol; 2014 Aug; 21(8):1076-1082. PubMed ID: 24313901 [TBL] [Abstract][Full Text] [Related]
19. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow. Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316 [TBL] [Abstract][Full Text] [Related]